A Safety and Efficacy Study of R935788 in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (AIHA)
Status:
Completed
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether fostamatinib is safe and effective in the
treatment of Warm Antibody Autoimmune Hemolytic Anemia (AIHA).